Eli Lil­ly cracks down on im­porters and dis­trib­u­tors of com­pound­ed Moun­jaro

Eli Lil­ly took le­gal ac­tion on Thurs­day to stop for­eign im­porters and do­mes­tic dis­trib­u­tors from sell­ing and dis­trib­ut­ing wa­tered-down ver­sions of its block­buster type 2 di­a­betes drug Moun­jaro.

The drug­mak­er filed a gen­er­al ex­clu­sion or­der and a cease-and-de­sist or­der at the In­ter­na­tion­al Trade Com­mis­sion in Wash­ing­ton, DC, ac­cord­ing to court doc­u­ments. The ac­cused par­ties are de­scribed as “on­line phar­ma­cies sell­ing low-grade tirzepatide … through mis­use of Lil­ly’s Moun­jaro trade­mark and/or false and mis­lead­ing state­ments re­gard­ing ap­proval and as­so­ci­a­tion.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER